Recruiting × Interventional × Uterine Cervical Neoplasms × Clear all PSI-Immune
Phase 2 Recruiting
880 enrolled
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
76 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
450 enrolled
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Phase 1/2 Recruiting
350 enrolled
PAROLA
Phase 3 Recruiting
510 enrolled
INDIGO
Phase NA Recruiting
11,200 enrolled
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
949 enrolled
TroFuse-020
Phase 3 Recruiting
686 enrolled
TroFuse-036
Phase 3 Recruiting
1,023 enrolled
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
Phase 1 Recruiting
70 enrolled
panSOHO
Phase 2 Recruiting
111 enrolled
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 Recruiting
1,006 enrolled
STEALTH-001
Phase 1 Recruiting
60 enrolled
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
Phase 3 Recruiting
398 enrolled
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Phase NA Recruiting
400 enrolled
SHIP-A-S01
Phase NA Recruiting
750 enrolled
Pap
Phase NA Recruiting
250 enrolled
RAD301
Phase 1 Recruiting
9 enrolled
Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana
Phase NA Recruiting
610 enrolled
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
Phase 2 Recruiting
89 enrolled
AppDate-You
Phase NA Recruiting
3,000 enrolled
MOTTO
Phase NA Recruiting
524 enrolled
BetaBart
Phase 1/2 Recruiting
61 enrolled
HypoRTCx-UG
Phase 2 Recruiting
278 enrolled
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
Phase 2 Recruiting
50 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
eVOLVE-02
Phase 2 Recruiting
257 enrolled
KOPRETINA
Phase NA Recruiting
15,000 enrolled
Reiki-Brachy
Phase 2 Recruiting
68 enrolled
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Phase 1 Recruiting
280 enrolled
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Phase 1/2 Recruiting
205 enrolled
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Phase 1 Recruiting
40 enrolled
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Phase 1 Recruiting
48 enrolled
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Phase NA Recruiting
558 enrolled
Keynote B59
Phase 1/2 Recruiting
317 enrolled
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
233 enrolled
PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer
Phase 2/3 Recruiting
120 enrolled
PNeoVCA
Phase 1/2 Recruiting
132 enrolled
PROPS GYN
Phase 2 Recruiting
25 enrolled
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Phase 4 Recruiting
100 enrolled
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
Phase 1 Recruiting
24 enrolled
POC
Phase NA Recruiting
5,000 enrolled
AIM-C1
Phase NA Recruiting
40 enrolled
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Phase 1 Recruiting
110 enrolled
A Study of YL202 in Patients With Advanced Solid Tumors
Phase 2 Recruiting
100 enrolled
Cervical Cancer Detection Using Optical Spectroscopy
Phase NA Recruiting
350 enrolled
Calla
Phase NA Recruiting
305 enrolled
Embrace Gyn
Phase NA Recruiting
70 enrolled
HPVDNA02
Phase NA Recruiting
64 enrolled
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Phase 1 Recruiting
200 enrolled